Latest Hospira Inc. Stories
- Hospira calls for continued support of extrapolation principle to help drive increased patient access to life-saving biologic medicines - LONDON, April 24, 2015 /PRNewswire/ --
LAKE FOREST, Ill., April 13, 2015 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and
LAKE FOREST, Ill., April 7, 2015 /PRNewswire/ -- Hospira, Inc.
-- Subsequent entry biologic (SEB) medicine provides a lower-cost, high-quality, safe and effective therapy for rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA)
-- Data presented at the National Kidney Foundation (NKF) Spring Meeting; single and multiple-dose pharmacokinetic and pharmacodynamic (PK/PD) studies support biosimilar application for Epoetin Hospira
LAKE FOREST, Ill., March 6, 2015 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), applauds Sandoz and the U.S.
-- Hungarian National Registry reports interim results following Inflectra therapy in 90 patients with Crohn's disease and ulcerative colitis BARCELONA and MADRID, Spain, Feb.
-- Major European markets can finally benefit from the availability of Inflectra following the patent expiry of reference product Remicade® (infliximab) LAKE FOREST, Ill., Feb.
LAKE FOREST, Ill., Feb. 12, 2015 /PRNewswire/ -- Hospira, Inc.
SAN DIEGO and LAKE FOREST, Ill., Feb. 10, 2015 /PRNewswire/ -- Pfenex Inc.
- An armed gangster.